Pregledni rad

THE USE OF ORAL HYPOGLYCEMIC AGENTS IN CHRONIC KIDNEY DISEASE

KRISTINA BLASLOV orcid.org/0000-0002-9747-8742 ; Klinička bolnica Merkur, Zagreg, Hrvatska
JELENA MARINKOVIĆ ; Klinički bolnički centar Sestre milosrdnice, Zavod za endokrinologiju, dijabetes i bolesti metabolizma Mladen Sekso, Zagreb, Hrvatska
IVAN KRULJAC ; Klinički bolnički centar Sestre milosrdnice, Zavod za endokrinologiju, dijabetes i bolesti metabolizma Mladen Sekso, Zagreb, Hrvatska

Sažetak

It is estimated that 200 million people suffer from chronic kidney disease (CKD) worldwide. Diabetes mellitus and associated disorders of hypertension and arteriosclerosis are the most common causes. Appropriate glucoregulation may postpone its onset and/or progression. Although insulin is the most commonly used antidiabetic agent in CKD patients, nowadays there is a wide spectrum of oral antidiabetic agents that can be used safely and effectively across different stages of CKD.

Ključne riječi

diabetes mellitus; chronic kidney disease; oral hypoglycemic agents

Hrčak ID:

193696

URI

https://hrcak.srce.hr/193696

Datum izdavanja:

13.2.2018.

Podaci na drugim jezicima: hrvatski

Posjeta: 1.874 *